2019 Scripps MD Anderson's Oncology Update

 

2019 Scripps MD Anderson's Oncology Update
Avatar

Scripps' 2019 ASCO Update on IO and Targeted Therapy in mRCC: New Data on First Line Intermediate/Poor Risk Disease

By 2019 Scripps MD Anderson's Oncology Update FEATURING David Quinn
August 30, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

22:28
Cardiovascular

Coagulopathy in COVID-19: What are the Venous Thromboembolism (VTE) Preven…

Feat. A. Spyropoulos
GU
27:22
2019 Scripps MD Anderson's Oncology Update

Scripps' 2019 ASCO Update on IO and Targeted Therapy in mRCC: New Data on …

Feat. D. Quinn
12:01
2019 Scripps MD Anderson's Oncology Update

Scripps' 2019 ASCO Update on Advanced Urothelial Cancer: First-Line Bevaci…

Feat. D. Quinn
09:52
2019 Scripps MD Anderson's Oncology Update

Scripps' 2019 ASCO Update on Prostate Cancer: New Data on Enzalutamide/Dar…

Feat. D. Quinn